4.7 Article

The Human Phenotype Ontology: Semantic Unification of Common and Rare Disease

Journal

AMERICAN JOURNAL OF HUMAN GENETICS
Volume 97, Issue 1, Pages 111-124

Publisher

CELL PRESS
DOI: 10.1016/j.ajhg.2015.05.020

Keywords

-

Funding

  1. Bundesministerium fur Bildung und Forschung [0313911]
  2. European Commission [602300]
  3. Raine Clinician Research Fellowship [20140101]
  4. National Health and Medical Research Council of Australia [APP1055319, 305444]
  5. NIH Office of the Director [1R24OD011883-01]
  6. Australian Research Council Discovery Early Career Researcher Award [DE120100508]
  7. BioMedBridges project - Research Infrastructures of the FP7 [284209]
  8. European Molecular Biology Laboratory Core Funds
  9. Basic Energy Sciences, Office of Science, US Department of Energy [DE-AC02-05CH11231]
  10. NIH [1R24OD011883-01]
  11. US Government
  12. Australian Research Council [DE120100508] Funding Source: Australian Research Council

Ask authors/readers for more resources

The Human Phenotype Ontology (HPO) is widely used in the rare disease community for differential diagnostics, phenotype-driven analysis of next-generation sequence-variation data, and translational research, but a comparable resource has not been available for common disease. Here, we have developed a concept-recognition procedure that analyzes the frequencies of HPO disease annotations as identified in over five million Pub Med abstracts by employing an iterative procedure to optimize precision and recall of the identified terms. We derived disease models for 3,145 common human diseases comprising a total of 132,006 HPO annotations. The HPO now comprises over 250,000 phenotypic annotations for over 10,000 rare and common diseases and can be used for examining the phenotypic overlap among common diseases that share risk alleles, as well as between Mendelian diseases and common diseases linked by genomic location. The annotations, as well as the HPO itself, are freely available.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available